VivoSeq
Other

Leukopenia

1

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Leukopenia is an early-stage landscape with 1 program across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical1

Mozobil

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

1

clinical trials

Recruiting1 · 100%

Clinical Trials

Trial Activity

A Phase I Study of MozobilTM in the Treatment of Patients With WHIMS
Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Preclinical·NCT00967785·20 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)